The MorphoSys Business Development & Licensing team approaches collaborations and licensing deals with the aim of addressing the needs and aligning the contributions of both partners. The ultimate goal for our award-winning BD&L team is to define the combined strengths of such partnerships to create promising therapeutics which make a difference for people suffering from diseases with high unmet medical need. Harboring sound scientific, clinical and drug development knowledge together with an industry-focused expertise in business intelligence, the team lays the groundwork for identifying and evaluating appropriate partners whose assets and expertise present a beneficial and complementary asset to the vast company portfolio.
Currently, we are actively looking for compounds in clinical development that fit into the MorphoSys portfolio. Primary focus are biologics in hemato-oncology and solid tumors. In addition, the team supports MorphoSys’ Research Organization in identifying new targets and technologies to complement the early stage pipeline.
The BD&L Teams are your primary contact for your target, technology and program offers as well in case of interest in our technologies and compounds.
